IPCA LABORATORIES LTD. - Updates on Open Offer to the Shareholder of Krebs Biochemicals & Industries

Download	< Back
02 Nov 2015
Arihant Capital Markets Limited ("Manager to the Offer") on behalf of Ipca Laboratories Limited ("Acquirer") has informed this Corrigendum to the DPS in respect of the Open Offer to the Equity Shareholders of Krebs Biochemicals and Industries Limited ("Target Company") pursuant to and in compliance with Regulation 3(1) and (4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and amendments thereto ("SEBI SAST Regulations'). This Corrigendum is being issued pursuant to changes / amendments advised by SEBI vide their letter dated October 21, 2015 and should be read in conjunction with the DPS published on February 24, 2015 in publications <BR><BR>The terms used in this Corrigendum to the DPS have the same meaning assigned to them in the DPS issued earlier, unless otherwise specified.
View all announcements for IPCA LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us